microdosing
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost
In a new study from the University of Southern Denmark, researchers have shed light on the effects of microdosing psilocybin, the active component in psychedelic mushrooms, in rats. The study offers preliminary evidence that small, regular doses of psilocybin could potentially offer therapeutic benefits, particularly in reducing stress-induced anhedonia (the inability to feel pleasure) and compulsive behaviors, without inducing significant anxiety or schizophrenic-like symptoms. The findings have been published in Molecular Psychiatry. Psilocybin, long known for its psychedelic effects, has re...
PsyPost
Adults with attention deficit hyperactivity disorder (ADHD) or severe ADHD symptoms who practiced microdosing with psychedelics reported increases in mindfulness after four weeks, according to new preliminary research published in Frontiers in Psychiatry. The findings underscore the importance of conducting future placebo-controlled studies to validate whether these observed changes can be replicated in a controlled experimental environment. ADHD affects millions of adults worldwide, characterized by symptoms like inattention, hyperactivity, and impulsivity. Many individuals with ADHD have tur...
PsyPost
In recent years, the trend of microdosing psychedelics has gained popularity, with enthusiasts touting a wide range of potential benefits, from enhanced creativity to improved mood and focus. However, a recent scientific review published in the Journal of Psychopharmacology has raised concerns about the potential health risks associated with long-term microdosing of psychedelics. In particular, researchers have expressed worry about the possible connection between chronic microdosing and a heart condition known as valvular heart disease (VHD). Microdosing involves taking small, sub-perceptual ...
PsyPost
The practice of “microdosing” appears to result in a decrease in emotional diversity, according to new research published in the Journal of Psychedelic Studies. Microdosing involves taking very small amounts of a psychedelic substance, such as LSD or psilocybin, in order to experience its subtle effects without inducing a full-blown psychedelic experience. Some people use microdosing to attempt to alleviate symptoms of depression and anxiety but others view it as a tool for self-enhancement. The idea is that this small amount of the substance can enhance creativity, focus, and mood, and potent...
PsyPost
A single, low dose of lysergic acid diethylamide (LSD) can increase reward-related brain activity, according to new research published in Neuropsychopharmacology. The study indicates that the psychedelic drug alters neuropsychological processes that tend to be blunted in patients with depression. The findings could have important implications for understanding the relationship between microdosing and mental health. Microdosing is becoming increasingly popular as a means of improving productivity, creativity, or overall psychological wellbeing. The practice involves taking very small doses of L...
PsyPost
Anecdotal evidence suggests that microdosing with psilocybin mushrooms offers mental health benefits. But a recent experimental study suggests that these purported benefits may be driven by users’ expectations. Findings from the placebo-controlled experiment were published in the journal Translational Psychiatry. Microdosing, the practice of consuming low, sub-hallucinogenic doses of psychedelics, appears to be growing in popularity among the public. People who engage in microdosing often do so for the potential mental health benefits, hoping the practice will improve their mood, concentration...
PsyPost
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら